Prev ABR (Clostridium Difficile Infectious Disease Program) is Buildings and Property in United States that focus on United States business. They cover business area such as portfolio, biologic compound, Maryland, United States, a series, beta-lactamase compound, multidrug-resistant infectious disease.
-
United States
-
4800 Hampden Lane
Suite 200
Bethesda, MD 20814
United States
Private
portfoliobiologic compoundMarylandUnited Statesa seriesbeta-lactamase compoundmultidrug-resistant infectious disease
* We use standard office opening hours in near Prev ABR (Clostridium Difficile Infectious Disease Program)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Prev ABR (Clostridium Difficile Infectious Disease Program) is Buildings and Property business from United States that founded in - ( years old in ), Prev ABR (Clostridium Difficile Infectious Disease Program) business is focusing on United States.
Prev ABR (Clostridium Difficile Infectious Disease Program) headquarter office and corporate office address is located in 4800 Hampden Lane Suite 200 Bethesda, MD 20814 United States.
Prev ABR (Clostridium Difficile Infectious Disease Program) was founded in United States.
In , Prev ABR (Clostridium Difficile Infectious Disease Program) is currently focus on United States sector.
Above is snippet of Google Trends for "United States" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Prev ABR (Clostridium Difficile Infectious Disease Program), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
